InsiderTrades.com logo

NTLA Insider Trading

Insider Ownership Percentage: 3.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $400,085.72

Intellia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Intellia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intellia Therapeutics Share Price & Price History

Current Price: $9.14
Price Change: ▼ Price Decrease of -0.08 (-0.87%)
As of 03/14/2025 05:00 PM ET

This chart shows the closing price history over time for NTLA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Intellia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2025Muna BhanjiDirectorSell265$9.97$2,642.0519,468View SEC Filing Icon  
1/3/2025John M LeonardCEOSell26,807$12.18$326,509.26941,115View SEC Filing Icon  
1/3/2025Michael P DubeCAOSell1,372$12.18$16,710.9645,640View SEC Filing Icon  
1/2/2025Eliana ClarkEVPSell556$12.03$6,688.6871,470View SEC Filing Icon  
10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.1247,012View SEC Filing Icon  
7/1/2024Eliana ClarkEVPSell405$22.93$9,286.6571,470View SEC Filing Icon  
3/4/2024James BastaEVPSell2,297$32.99$75,778.0381,571View SEC Filing Icon  
1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.2543,927View SEC Filing Icon  
1/3/2024David LebwohlEVPSell5,843$29.46$172,134.7854,372View SEC Filing Icon  
1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.9040,585View SEC Filing Icon  
1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58846,486View SEC Filing Icon  
10/31/2023Muna BhanjiDirectorSell265$23.90$6,333.5011,996View SEC Filing Icon  
7/31/2023Muna BhanjiDirectorSell265$42.33$11,217.4512,261View SEC Filing Icon  
7/6/2023Muna BhanjiDirectorSell1,867$39.30$73,373.1012,526View SEC Filing Icon  
7/3/2023Eliana ClarkEVPSell360$40.51$14,583.6045,146View SEC Filing Icon  
6/20/2023Eliana ClarkEVPSell5,000$45.00$225,000.0045,146View SEC Filing Icon  
1/4/2023Glenn GoddardCFOSell2,427$37.21$90,308.6715,404View SEC Filing Icon  
1/4/2023John M LeonardCEOSell6,673$37.21$248,302.33766,825View SEC Filing Icon  
1/4/2023Laura Sepp-LorenzinoEVPSell2,508$37.21$93,322.6819,959View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Intellia Therapeutics (NASDAQ:NTLA)

88.77% of Intellia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NTLA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Intellia Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/25/2025Polar Asset Management Partners Inc.282,400$3.29M0.0%+1,144.1%0.277%Search for SEC Filing on Google Icon
2/19/2025GF Fund Management CO. LTD.2,139$25K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC483,185$5.63M0.0%+5.0%0.474%Search for SEC Filing on Google Icon
2/17/2025Voloridge Investment Management LLC1,526,994$17.81M0.1%+226.8%1.499%Search for SEC Filing on Google Icon
2/17/2025Vestal Point Capital LP525,000$6.12M0.4%N/A0.515%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC101,417$1.18M0.0%+58.8%0.100%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP1,998,317$23.30M0.1%+94.5%1.962%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP1,843,743$21.50M0.0%+88.1%1.810%Search for SEC Filing on Google Icon
2/17/2025Teza Capital Management LLC26,065$0.30M0.0%+74.3%0.026%Search for SEC Filing on Google Icon
2/17/2025Tema Etfs LLC148,167$1.73M0.7%N/A0.145%Search for SEC Filing on Google Icon
2/17/2025Second Line Capital LLC131,122$1.53M0.4%N/A0.129%Search for SEC Filing on Google Icon
2/17/2025Shell Asset Management Co.29,975$0.35M0.0%+45.7%0.029%Search for SEC Filing on Google Icon
2/17/2025Sherbrooke Park Advisers LLC22,515$0.26M0.1%N/A0.022%Search for SEC Filing on Google Icon
2/17/2025Sphera Funds Management LTD.466,080$5.43M1.0%+60.1%0.458%Search for SEC Filing on Google Icon
2/17/2025Polar Asset Management Partners Inc.282,400$3.29M0.0%+1,144.1%0.277%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC33,404$0.39M0.0%+38.0%0.033%Search for SEC Filing on Google Icon
2/17/2025Patient Square Capital LP215,981$2.52M0.9%+68.0%0.212%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC260,697$3.04M0.0%-28.7%0.256%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC668,926$7.80M0.0%+190.5%0.657%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.227,255$2.65M0.0%+7.5%0.223%Search for SEC Filing on Google Icon
2/17/2025Lazard Asset Management LLC109,500$1.28M0.0%+7.3%0.108%Search for SEC Filing on Google Icon
2/17/2025Hudson Bay Capital Management LP512,300$5.97M0.0%+52.9%0.503%Search for SEC Filing on Google Icon
2/17/2025Granahan Investment Management LLC306,510$3.57M0.1%+8.1%0.301%Search for SEC Filing on Google Icon
2/17/2025Ensign Peak Advisors Inc39,169$0.46M0.0%+2.9%0.038%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG252,501$2.94M0.0%+12.1%0.248%Search for SEC Filing on Google Icon
2/17/2025Cetera Investment Advisers13,148$0.15M0.0%-26.7%0.013%Search for SEC Filing on Google Icon
2/17/2025Brevan Howard Capital Management LP108,351$1.26M0.0%+626.3%0.106%Search for SEC Filing on Google Icon
2/17/2025Bridgefront Capital LLC24,521$0.29M0.1%+68.1%0.024%Search for SEC Filing on Google Icon
2/17/2025Capstone Investment Advisors LLC108,665$1.27M0.0%+77.8%0.107%Search for SEC Filing on Google Icon
2/17/2025Baker BROS. Advisors LP644,116$7.51M0.1%N/A0.632%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE639,696$7.46M0.0%-10.7%0.628%Search for SEC Filing on Google Icon
2/17/2025Benjamin Edwards Inc.64,065$0.75M0.0%+11.1%0.063%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets438,458$5.11M0.0%+78.0%0.430%Search for SEC Filing on Google Icon
2/17/2025Algert Global LLC69,354$0.81M0.0%+13.6%0.068%Search for SEC Filing on Google Icon
2/17/2025Aptus Capital Advisors LLC139,278$1.62M0.0%N/A0.137%Search for SEC Filing on Google Icon
2/14/2025PDT Partners LLC327,608$3.82M0.3%+2,111.5%0.322%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC145,502$1.70M0.0%+7.6%0.143%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp979,137$11.42M0.0%+13.0%0.961%Search for SEC Filing on Google Icon
2/14/2025The Manufacturers Life Insurance Company 47,915$0.56M0.0%-10.5%0.047%Search for SEC Filing on Google Icon
2/14/2025Aquatic Capital Management LLC182,434$2.13M0.1%+98.7%0.179%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC5,242$61K0.0%+47.7%0.005%Search for SEC Filing on Google Icon
2/14/2025Two Sigma Securities LLC13,108$0.15M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/14/2025Voya Investment Management LLC28,829$0.34M0.0%-7.1%0.028%Search for SEC Filing on Google Icon
2/14/2025Syon Capital LLC14,008$0.16M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/14/2025Coppell Advisory Solutions LLC11,591$0.13M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD39,295$0.46M0.0%-93.3%0.039%Search for SEC Filing on Google Icon
2/14/2025Hsbc Holdings PLC51,536$0.60M0.0%+47.4%0.051%Search for SEC Filing on Google Icon
2/14/2025Stifel Financial Corp397,761$4.64M0.0%+320.4%0.391%Search for SEC Filing on Google Icon
2/14/2025Tower Research Capital LLC TRC 8,148$95K0.0%+28.5%0.008%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC59,187$0.69M0.0%+6.3%0.058%Search for SEC Filing on Google Icon
2/14/2025Curi RMB Capital LLC29,881$0.35M0.0%-23.7%0.029%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP1,976,212$23.04M0.0%+36.5%1.940%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP95,339$1.11M0.0%N/A0.094%Search for SEC Filing on Google Icon
2/13/2025Jump Financial LLC362,637$4.23M0.1%+94.2%0.356%Search for SEC Filing on Google Icon
2/13/2025Guggenheim Capital LLC59,589$0.70M0.0%-11.0%0.059%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd43,908$0.51M0.0%+194.6%0.043%Search for SEC Filing on Google Icon
2/13/2025Mariner LLC14,820$0.17M0.0%-14.4%0.015%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC311,632$3.63M0.0%+6.4%0.306%Search for SEC Filing on Google Icon
2/13/2025Evolutionary Tree Capital Management LLC47,406$0.55M0.6%+34.0%0.047%Search for SEC Filing on Google Icon
2/13/2025Rockefeller Capital Management L.P.137,838$1.61M0.0%+81.3%0.135%Search for SEC Filing on Google Icon
2/13/2025Sterling Capital Management LLC3,198$37K0.0%+866.2%0.003%Search for SEC Filing on Google Icon
2/13/2025Kennedy Capital Management LLC12,847$0.15M0.0%+22.7%0.013%Search for SEC Filing on Google Icon
2/13/2025Raymond James Financial Inc.411,077$4.79M0.0%N/A0.404%Search for SEC Filing on Google Icon
2/13/2025Martingale Asset Management L P21,399$0.25M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC98,700$1.15M0.0%N/A0.097%Search for SEC Filing on Google Icon
2/13/2025FIL Ltd159,671$1.86M0.0%+737.6%0.157%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc106,767$1.25M0.0%+10.6%0.105%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.96,434$1.12M0.0%+4.0%0.095%Search for SEC Filing on Google Icon
2/13/2025Bank of Montreal Can35,586$0.42M0.0%N/A0.035%Search for SEC Filing on Google Icon
2/13/2025Federated Hermes Inc.3,845$45K0.0%-99.9%0.004%Search for SEC Filing on Google Icon
2/13/2025Aristides Capital LLC15,600$0.18M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/13/2025Himension Capital Singapore PTE. LTD.985,715$11.49M0.8%-8.4%0.968%Search for SEC Filing on Google Icon
2/13/2025Russell Investments Group Ltd.117,415$1.37M0.0%-40.9%0.115%Search for SEC Filing on Google Icon
2/13/2025Envestnet Asset Management Inc.66,654$0.78M0.0%-16.7%0.065%Search for SEC Filing on Google Icon
2/13/2025Sit Investment Associates Inc.85,500$1M0.0%+42.7%0.084%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN277,692$3.24M0.0%+38.3%0.273%Search for SEC Filing on Google Icon
2/13/2025Resona Asset Management Co. Ltd.3,668$43K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/12/2025ExodusPoint Capital Management LP105,827$1.23M0.0%+98.4%0.104%Search for SEC Filing on Google Icon
2/12/2025Arete Wealth Advisors LLC10,272$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/12/2025Bryce Point Capital LLC26,083$0.30M0.1%N/A0.026%Search for SEC Filing on Google Icon
2/12/2025Trexquant Investment LP667,632$7.79M0.1%N/A0.656%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC2,389,240$27.87M0.0%+2.0%2.346%Search for SEC Filing on Google Icon
2/12/2025Alliancebernstein L.P.265,318$3.09M0.0%-87.9%0.260%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP699,814$8.16M0.0%+8.5%0.687%Search for SEC Filing on Google Icon
2/12/2025CIBC Private Wealth Group LLC4,611$55K0.0%-45.0%0.005%Search for SEC Filing on Google Icon
2/12/2025Schroder Investment Management Group24,000$0.27M0.0%-72.1%0.024%Search for SEC Filing on Google Icon
2/12/2025Norges Bank30,010$0.35M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/12/2025IQ EQ FUND MANAGEMENT IRELAND Ltd54,657$0.64M0.1%+137.3%0.054%Search for SEC Filing on Google Icon
2/12/2025NEOS Investment Management LLC127,826$1.49M0.0%-18.2%0.126%Search for SEC Filing on Google Icon
2/12/2025Mitsubishi UFJ Asset Management Co. Ltd.17,293$0.21M0.0%+67.6%0.017%Search for SEC Filing on Google Icon
2/11/2025EntryPoint Capital LLC32,425$0.38M0.2%N/A0.032%Search for SEC Filing on Google Icon
2/11/2025Interchange Capital Partners LLC14,451$0.16M0.1%-28.8%0.014%Search for SEC Filing on Google Icon
2/11/2025Congress Wealth Management LLC DE 20,000$0.23M0.0%N/A0.020%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.10,190,053$118.82M0.0%+5.8%10.005%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC54,041$0.63M0.0%-4.5%0.053%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS21,600$0.25M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/11/2025American Century Companies Inc.453,821$5.29M0.0%+3.5%0.446%Search for SEC Filing on Google Icon
2/11/2025Contrarius Group Holdings Ltd1,011,863$11.80M0.7%N/A0.993%Search for SEC Filing on Google Icon
2/11/2025Teacher Retirement System of Texas28,652$0.33M0.0%+24.6%0.028%Search for SEC Filing on Google Icon
2/11/2025Privium Fund Management B.V.27,709$0.32M0.1%+125.3%0.027%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Intellia Therapeutics logo
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Read More on Intellia Therapeutics

Today's Range

Now: $9.14
Low: $8.97
High: $9.60

50 Day Range

MA: $10.36
Low: $9.10
High: $12.80

52 Week Range

Now: $9.14
Low: $8.30
High: $28.54

Volume

2,063,212 shs

Average Volume

3,267,837 shs

Market Capitalization

$946.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.97

Who are the company insiders with the largest holdings of Intellia Therapeutics?

Intellia Therapeutics' top insider investors include:
  1. John M Leonard (CEO)
  2. James Basta (EVP)
  3. Eliana Clark (EVP)
  4. David Lebwohl (EVP)
  5. Michael P Dube (CAO)
  6. Laura Sepp-Lorenzino (EVP)
  7. Glenn Goddard (CFO)
  8. Muna Bhanji (Director)
Learn More about top insider investors at Intellia Therapeutics.

Who are the major institutional investors of Intellia Therapeutics?

Intellia Therapeutics' top institutional shareholders include:
  1. ARK Investment Management LLC — 12.31%
  2. Vanguard Group Inc. — 10.00%
  3. Regeneron Pharmaceuticals Inc. — 3.64%
  4. Sumitomo Mitsui Trust Group Inc. — 2.94%
  5. Nikko Asset Management Americas Inc. — 2.94%
  6. Geode Capital Management LLC — 2.35%
Learn More about top institutional investors of Intellia Therapeutics stock.

Which institutional investors are selling Intellia Therapeutics stock?

Within the previous quarter, NTLA stock was sold by these institutional investors:
  1. Federated Hermes Inc.
  2. Alliancebernstein L.P.
  3. Price T Rowe Associates Inc. MD
  4. Chevy Chase Trust Holdings LLC
  5. Sumitomo Mitsui Trust Group Inc.
  6. Nikko Asset Management Americas Inc.
  7. Nuveen Asset Management LLC
  8. Walleye Capital LLC
In the previous year, company insiders that have sold Intellia Therapeutics company stock include:
  1. John M Leonard (CEO)
  2. James Basta (EVP)
  3. Eliana Clark (EVP)
  4. David Lebwohl (EVP)
Learn More investors selling Intellia Therapeutics stock.

Which institutional investors are buying Intellia Therapeutics stock?

Within the last quarter, NTLA stock was purchased by institutional investors including:
  1. Regeneron Pharmaceuticals Inc.
  2. Voloridge Investment Management LLC
  3. Contrarius Group Holdings Ltd
  4. Two Sigma Advisers LP
  5. Two Sigma Investments LP
  6. Trexquant Investment LP
  7. Baker BROS. Advisors LP
  8. Vanguard Group Inc.